EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monocytes and Macrophages in Systemic Sclerosis: Profibrotic Functions and Emerging IRF8-Dependent Regulation

Yukie Yamaguchi

Sclerosis · 11.11.2026 · 4 (4) · 33

DOI: 10.3390/sclerosis4040033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sclerosis, online erschienen am 11.11.2026. Verfasst von Yukie Yamaguchi. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc) is a clinically distinct autoimmune connective tissue disease characterized by immune dysregulation, vasculopathy, and excessive fibrosis. Monocytes and macrophages (Mo/Mφ) contribute to these processes through heterogeneous tissue-dependent states that are not sufficiently represented by a binary M1/M2 framework. Human blood and tissue studies, including recent single-cell and spatial analyses, have repeatedly identified hybrid activated monocytes and monocyte-derived macrophages associated with skin or lung involvement. Classical studies have established several Mo/Mφ-linked profibrotic mechanisms in SSc, including the secretion of cytokines, chemokines, and growth factors; organization of macrophage–stromal signaling niches; production and remodeling of the extracellular matrix; monocyte plasticity toward vascular and mesenchymal lineages; and defective efferocytosis and resolution. Upstream of these effector outputs, transcriptional, epigenetic, and metabolic programs are increasingly recognized as key regulators. As one example relevant to Mo/Mφ differentiation, we have focused on interferon regulatory factor 8 (IRF8), showing reduced IRF8 expression in circulating monocytes from diffuse cutaneous SSc associated with skin fibrosis. Experimentally, IRF8 silencing and myeloid-specific Irf8 deletion promote profibrotic features; however, the functional direction of IRF8 across lineages and tissues remains incompletely defined. Several established and emerging SSc therapeutic strategies are thought to act at least in part on the Mo/Mφ compartment, although direct SSc-derived cellular evidence remains limited. This review synthesizes Mo/Mφ diversity and effector functions in SSc and outlines therapeutic implications, highlighting the need for lineage- and tissue-resolved profiling of Mo/Mφ and mechanistic dissection of their upstream programs as a foundation for rational therapeutic strategies in SSc.

Zitieren

APA

Yamaguchi, Y. (2026). Monocytes and Macrophages in Systemic Sclerosis: Profibrotic Functions and Emerging IRF8-Dependent Regulation. Sclerosis, 4(4), 33. https://doi.org/10.3390/sclerosis4040033

Vancouver

Yamaguchi Y. Monocytes and Macrophages in Systemic Sclerosis: Profibrotic Functions and Emerging IRF8-Dependent Regulation. Sclerosis. 2026;4(4):33. doi:10.3390/sclerosis4040033

BibTeX
@article{Yamaguchi2026,
  author = {Yamaguchi, Yukie},
  title = {Monocytes and Macrophages in Systemic Sclerosis: Profibrotic Functions and Emerging IRF8-Dependent Regulation},
  journal = {Sclerosis},
  year = {2026},
  volume = {4},
  number = {4},
  pages = {33},
  doi = {10.3390/sclerosis4040033}
}
Kostenlos starten →